Tonix Pharmaceuticals Hol... (TNXP)

AI Score

Unlock

7.43

-0.43 (-5.47%)

At close: Mar 03, 2025, 3:59 PM

7.38

-0.74%

After-hours: Mar 03, 2025, 04:00 PM EST

Tonix Pharmaceuticals Balance Sheet Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08
Cash & Equivalents	24.95M	120.23M	178.66M	77.07M	11.25M	25.03M	25.5M	18.94M	19.18M	38.18M	8.2M	1.79M	41.12K	4.62K	12.61K	40.48K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.18M	23.84M	n/a	n/a	n/a	n/a	n/a	425.00	4.88K
Long-Term Investments	n/a	241K	240K	240K	100K	100K	89K	89K	189K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.13M	143K	259K	245K	100K	100K	100K	100K	189K	-13.23B	60K	60.27K	256.34K	n/a	n/a	n/a
Receivables	4.59M	n/a	7.73M	7.63M	n/a	n/a	n/a	n/a	2.83M	n/a	n/a	n/a	n/a	n/a	n/a	552.00
Inventory	14.15M	-8.04M	-7.73M	-7.63M	-1.01M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	4.08M	10.55M	2.66M	3.29M	1.69M	1.02M	453K	627K	517K	1.19M	858K	225K	102.43K	23.31K	n/a	n/a
Total Current Assets	47.77M	130.78M	189.05M	87.99M	13.95M	26.06M	26.44M	27.14M	46.36M	39.04M	8.63M	2.01M	143.55K	4.62K	13.03K	45.91K
Property-Plant & Equipment	94.85M	94.53M	51.47M	9.83M	390K	43K	91K	150K	350K	328K	45K	46.89K	25.55K	n/a	n/a	n/a
Goodwill & Intangibles	10.71M	120K	120K	120K	120K	120K	120K	120K	120K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	106.69M	94.91M	51.85M	10.19M	610K	263K	311K	370K	659K	506K	105K	107.16K	281.89K	n/a	n/a	n/a
Total Assets	154.46M	225.69M	240.9M	98.18M	14.56M	26.32M	26.75M	27.51M	47.02M	39.54M	8.74M	2.12M	425.45K	4.62K	13.03K	45.91K
Account Payables	3.78M	8.07M	13.28M	4.6M	3.07M	1.4M	1.3M	872K	3.05M	1.49M	765K	825K	695.2K	317.75K	988.00	n/a
Deferred Revenue	2.98M	3.27M	2.83M	2.17M	704K	475K	519K	504K	2.25M	n/a	n/a	n/a	48.53K	n/a	n/a	n/a
Short-Term Debt	2.62M	432K	489K	595K	352K	n/a	n/a	n/a	n/a	n/a	280K	n/a	150K	n/a	n/a	n/a
Other Current Liabilities	9.5M	6.41M	5.11M	2.46M	1.01M	1.25M	830K	1.24M	3.6M	1.9M	1.17M	313K	80.08K	22.53K	n/a	3K
Total Current Liabilities	18.88M	18.18M	21.72M	9.82M	5.13M	2.65M	2.13M	2.12M	6.65M	3.38M	2.21M	1.14M	925.28K	10.3K	988.00	3K
Long-Term Debt	7.19M	328K	467K	716K	6K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.93M	n/a	n/a	n/a
Other Long-Term Liabilities	22.86M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	68K	13K	n/a	29.08K	n/a	n/a	n/a
Total Long-Term Liabilities	30.05M	328K	467K	716K	6K	n/a	12K	33K	106K	68K	13K	19.71K	1.95M	n/a	n/a	n/a
Total Liabilities	48.93M	18.51M	22.18M	10.54M	5.14M	2.65M	2.14M	2.15M	6.76M	3.45M	2.22M	1.16M	2.88M	10.3K	988.00	3K
Total Debt	9.81M	760K	956K	1.31M	358K	n/a	n/a	n/a	n/a	n/a	280K	n/a	2.08M	n/a	n/a	n/a
Common Stock	59K	76K	496K	206K	9K	3K	8K	4K	19K	11K	6K	43.18K	27.07K	5.5K	5.5K	5.5K
Retained Earnings	-600.66M	-470.04M	-359.82M	-267.53M	-217.07M	-188.45M	-162.36M	-141.24M	-102.4M	-54.34M	-26.73M	-15.84M	-6.39M	-70.68K	-52.96K	-22.09K
Comprehensive Income	-232K	-167K	-92K	-62K	-46K	-41K	-12K	-7K	-17K	2K	-1K	-31.64K	-17.31K	n/a	n/a	n/a
Shareholders Equity	105.53M	207.18M	218.72M	87.65M	9.42M	23.66M	24.62M	25.36M	40.26M	36.09M	6.51M	958.71K	-2.45M	-5.68K	12.04K	42.91K
Total Investments	900K	241K	240K	240K	100K	100K	89K	7.18M	23.84M	n/a	n/a	n/a	n/a	n/a	425.00	4.88K